PRAME and neoplasm: In addition, PRAME and CYP26B1 were found to be related to the retinoic acid signaling pathway [25, 26]. PRAME was reported to be involved in tumor progression rather than tumor initiation by suppressing retinoic acid signaling which regulates gene expression in melanomas [25].